Form 8-K - Current report:
SEC Accession No. 0001157523-21-000935
Filing Date
2021-07-28
Accepted
2021-07-28 07:22:38
Documents
13
Period of Report
2021-06-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K a52467373.htm   iXBRL 8-K 34038
2 EXHIBIT 99.1 a52467373_ex991.htm EX-99.1 1034836
  Complete submission text file 0001157523-21-000935.txt   1263205

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA teva-20210630.xsd EX-101.SCH 3926
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20210630_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20210630_pre.xml EX-101.PRE 16044
6 EXTRACTED XBRL INSTANCE DOCUMENT a52467373_htm.xml XML 4257
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 211119835
SIC: 2834 Pharmaceutical Preparations